MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the inhibition of mTOR kinases by PP242 or of Bcr-Abl by imatinib leads to CML cell death, revealing the significance of translation regulation in the pathogenesis of leukaemia [18,23].